Salience Clinical

Salience Clinical, LLC is a boutique consultancy providing senior-level medical affairs and regulatory expertise to pharmaceutical, biotechnology, and medical technology organizations. Its work centers on central nervous system (CNS) and biologics programs, helping teams navigate complex development decisions and prepare for launches. Services include medical affairs strategy, launch readiness, real-world evidence (RWE) strategy, and regulatory support.

The consultancy brings deep subject-matter knowledge, an agile approach, and a global perspective to client engagements. Its experience includes biomarker-driven precision medicine strategies, integrating plasma biomarkers and PET imaging to inform clinical development, and supporting complex health authority interactions. Salience Clinical has also contributed to regulatory submission sections and served as a strategic interface with the FDA and EMA. For cell-based therapies, biologics, and regenerative medicine, the firm offers senior-level clinical leadership and development strategy, including support for global Phase III programs. Salience Clinical works with sponsors to clarify priorities, address scientific and regulatory risks, and shape rigorous, viable pathways for advancing innovative therapies.